Gaush Meditech Maintains Stable Share Structure in August 2026 Monthly Return

Bulletin Express

Sep 01

Gaush Meditech Ltd. filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either authorised or issued share capital during the month.

The company’s authorised share capital remains at 500.00 million ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000. Issued share capital is unchanged at 147.89 million ordinary shares, and no treasury shares were held or created.

Public-float requirements under Hong Kong Main Board Rule 13.32D(1) were met, with the free-float level exceeding the prescribed minimum threshold of 25 percent of issued shares.

Gaush Meditech reported no share options, warrants, convertibles, or other equity-linked instruments outstanding or exercised, underscoring a stable capital structure for the month. The return was submitted to Hong Kong Exchanges and Clearing Limited on 01 September 2026 and signed by Chairman and Executive Director Gao Tieta.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/news/1102210735"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102210735\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102210735?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-01 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102210735","market":"hk","top_or_hot":-1,"title":"Gaush Meditech Maintains Stable Share Structure in August 2026 Monthly Return","media":"Bulletin Express","content":"<p>Gaush Meditech Ltd. filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either authorised or issued share capital during the month.</p>\n<p>The company’s authorised share capital remains at 500.00 million ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000. Issued share capital is unchanged at 147.89 million ordinary shares, and no treasury shares were held or created.</p>\n<p>Public-float requirements under Hong Kong Main Board Rule 13.32D(1) were met, with the free-float level exceeding the prescribed minimum threshold of 25 percent of issued shares.</p>\n<p>Gaush Meditech reported no share options, warrants, convertibles, or other equity-linked instruments outstanding or exercised, underscoring a stable capital structure for the month. The return was submitted to Hong Kong Exchanges and Clearing Limited on 01 September 2026 and signed by Chairman and Executive Director Gao Tieta.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gaush Meditech Maintains Stable Share Structure in August 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGaush Meditech Maintains Stable Share Structure in August 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-01 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Gaush Meditech Ltd. filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either authorised or issued share capital during the month.</p>\n<p>The company’s authorised share capital remains at 500.00 million ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000. Issued share capital is unchanged at 147.89 million ordinary shares, and no treasury shares were held or created.</p>\n<p>Public-float requirements under Hong Kong Main Board Rule 13.32D(1) were met, with the free-float level exceeding the prescribed minimum threshold of 25 percent of issued shares.</p>\n<p>Gaush Meditech reported no share options, warrants, convertibles, or other equity-linked instruments outstanding or exercised, underscoring a stable capital structure for the month. The return was submitted to Hong Kong Exchanges and Clearing Limited on 01 September 2026 and signed by Chairman and Executive Director Gao Tieta.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02407","symbol_name":"高视医疗","start_time":0,"source_url":"","article_id":"1102210735","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102210735","pubTimestamp":1788254693,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Gaush Meditech Ltd. filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The company’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02407":"高视医疗"},"translate_title":"Gaush Meditech 2026 年 8 月月回报保持稳定的份额结构","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02407":1},"content_text":"Gaush Meditech Ltd. filed its monthly return for the period ended 31 August 2026, confirming that no changes occurred in either authorised or issued share capital during the month.\nThe company’s authorised share capital remains at 500.00 million ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000. Issued share capital is unchanged at 147.89 million ordinary shares, and no treasury shares were held or created.\nPublic-float requirements under Hong Kong Main Board Rule 13.32D(1) were met, with the free-float level exceeding the prescribed minimum threshold of 25 percent of issued shares.\nGaush Meditech reported no share options, warrants, convertibles, or other equity-linked instruments outstanding or exercised, underscoring a stable capital structure for the month. The return was submitted to Hong Kong Exchanges and Clearing Limited on 01 September 2026 and signed by Chairman and Executive Director Gao Tieta.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}